Finally, all cell lines which have been established by using a virus transformation (e.g. EBV-transformed B-lymphocytes, such as the Namalva cell line (Klein et al., 1972; Butler, 1991) ) are potentially able to produce the virus used for the transformation and therefore also represent a potential infection risk for the operators, the cell culture lab, and the patients receiving a biological produced with such cell lines.